Lee B P, Kupferman A, Leibowitz H M
Arch Ophthalmol. 1985 Jan;103(1):95-7. doi: 10.1001/archopht.1985.01050010101028.
We studied the effect of suprofen, a new ophthalmic nonsteroidal anti-inflammatory agent, on corneal wound healing. Nine-millimeter, central, perforating corneal wounds were made in albino rabbits and sutured with 10-0 nylon. The animals were randomly treated with balanced salt solution, suprofen vehicle, 1% suprofen, or 0.1% dexamethasone sodium phosphate administered topically for six days. On the seventh postoperative day, the sutures were removed and, in situ, the intraocular pressure was increased in a controlled manner until the wound burst. Dexamethasone applied four times a day significantly inhibited corneal wound healing, whereas suprofen given as often as hourly did not. Pretreatment with hourly administered suprofen for two days prior to surgery, in addition to the same postoperative hourly therapy, also did not significantly decrease stromal wound strength.
我们研究了一种新型眼科非甾体抗炎药舒洛芬对角膜伤口愈合的影响。在白化兔身上制作9毫米的中央穿孔性角膜伤口,并用10-0尼龙线缝合。动物被随机给予平衡盐溶液、舒洛芬赋形剂、1%舒洛芬或0.1%磷酸地塞米松钠,局部给药6天。术后第7天,拆除缝线,并在原位以可控方式升高眼内压直至伤口破裂。每天应用4次地塞米松显著抑制角膜伤口愈合,而每小时给药的舒洛芬则没有。术前连续两天每小时给予舒洛芬预处理,术后同样每小时进行治疗,也未显著降低基质伤口强度。